FdaApplication
ANDA 209748
Identifiers
- fda_app_no: ANDA209748
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2024-01-04 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 12.5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products